Curis · 5 hours ago
Customer Service Representative
Lincolnwood, IL
Full-time
Onsite
New Grad, Entry LevelCuris Services is seeking a dedicated and detail-oriented Customer Service Representative to manage communications with liable parties regarding outstanding debts. This role involves making outbound calls, negotiating payment plans, and providing excellent customer service while ensuring accurate account management.
BiotechnologyHealth CareMedical
Responsibilities
Make over 125 outbound calls daily to debtors to clarify and communicate account status
Negotiate payment plans that lead to efficient and effective resolutions of outstanding debts
Provide excellent customer service with regular follow-ups and clear communication
Send letters and other mailings to liable parties informing them of debt and payment requirements
Log calls, emails, letters, and other actions taken to track the department's progress and efforts
Utilize tracking software to monitor account status and provide real-time updates
Perform other duties as assigned to support the team and department goals
Qualification
Required
Strong phone etiquette with the ability to be persistent yet compassionate when dealing with customers
Previous customer service experience in any capacity that involves communication with customers over the phone
Comfortable making over 125 outbound calls daily
Experience with debt collection, particularly for amounts up to $30,000
Knowledge of various insurance and payer sources (e.g., Private Pay, Medicaid, Medicare)
Proficiency in Microsoft Office Suite (Excel, Word, etc.) and the ability to quickly learn other software tools
Preferred
Exceptional communication and negotiation skills
Ability to work independently and as part of a team
Strong attention to detail and organizational skills
Ability to stay motivated and persistent while maintaining professionalism
Ability to thrive in a fast-paced environment, managing multiple tasks efficiently
Company
Curis
Curis is a developed erivedge, a capsule manufactured for the treatment of adults with skin cancer.
Founded in 2000
11-50 employees
Funding
Current Stage
Public CompanyTotal Funding
$274MKey Investors
GenentechDebiopharm Group
2026-01-07Post Ipo Equity· $80.8M
2025-07-02Post Ipo Equity· $7M
2024-10-29Post Ipo Equity· $12.1M
Leadership Team
James Dentzer
Chief Executive Officer
David Tuck
Senior Vice President, Clinical & Translational Sciences
Recent News
thefly.com
2026-01-08
Company data provided by crunchbase